FindTrial
Sign In

Side effects in cancer patients using medicines for their treatment.

Adverse Drug Reaction monitoring in oncology patients receiving chemotherapy for generating safety indicators - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/074525
Enrollment
150
Registered
2024-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: NA: NA

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients under chemotherapeutic regimen, developed ADR and willing to participate.

Exclusion criteria

Exclusion criteria: Outpatients Not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
1.The incidence rate for ADRs in the study population will be identified. 2. The causality of ADRs will be identified.Timepoint: Just 1 time point after the participant has developed adverse drug reaction—

Secondary

MeasureTime frame
A list of indicators for ADRs will be identifiedTimepoint: At the end of the study—

Countries

India

Contacts

Public ContactDr Rajesh V

Kasturba Medical College, Manipal Academy of Higher Education

vasudev.bhat@manipal.edu9619114703

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026